Add a listing
    Add a listing

    Selphagy

      Drugs that activate chaperone-mediated autophagy.

    General
    • Headquarters

      Boston, Massachusetts 02116, United States

    • Founders & Team

      Ana Maria Cuervo, David Sinclair

    • Year Founded

      2018

    • Number of employees

      50

    • Company type

      Private company

    • Investors

      Life Biosciences

    Technical Details
    • Aging Target

      Loss of proteostasis

    • Disease indication

      Alzheimer's

    • Product modality

      small molecule drugs

    About

    Selphagy is a company co-founded by Ana Maria Cuervo, a researcher at Einstein College of Medicine. The company is developing small molecule drugs to enhance chaperone-mediated autophagy in order to treat neurodegenerative disease.

    How much is an extra decade of life worth to you? Make a bet on longevity science today.

    Donate to Impetus Grants

    You May Also Be Interested In